Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2025-12-24 @ 3:00 PM
NCT ID:
NCT02627859
Brief Summary:
26 week open label study of treatment with Durolane for OA pain of the ankle
Detailed Description:
Single injection Durolane in patients with mild to moderate OA of the ankle.
Study:
NCT02627859
Study Brief:
Protocol Section:
NCT02627859